{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:11:14Z","timestamp":1790111474411,"version":"4.0.1"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>An adverse prognostic impact of statin use in lymphoma was first suspected from <jats:italic>in vitro<\/jats:italic> data showing an impairment of anti\u2010CD20 antibody binding. However, further clinical studies suggested an improved outcome associated with their use in hematological malignancies. In particular, a survival benefit was reported for patients with follicular lymphoma on statins. Our objective was to assess the outcome of follicular lymphoma patients treated in the PRIMA study with immunochemotherapy according to the use of statins. Among the 1,217 patients enrolled in the PRIMA study, 1,135 were included in the present study. Concomitant treatments at registration were available for all patients. Among those 1,135 patients, 119 were on statins (10.5%) at diagnosis. Adverse events frequencies, event\u2010free survival (EFS), time to next lymphoma treatment (TTNLT), time to next chemotherapy (TTNCT), and overall survival (OS) were evaluated according to the use of statins. The rates of overall and specific cardiovascular adverse events between the two groups of patients were comparable both during induction and maintenance. Outcome in terms of response rates or EFS, TTNLT, TTNCT, and OS were similar regardless of the use of statins (<jats:italic>P<\/jats:italic>\u2009=\u20090.57, <jats:italic>P<\/jats:italic>\u2009=\u20090.85, <jats:italic>P<\/jats:italic>\u2009=\u20090.30, and <jats:italic>P<\/jats:italic>\u2009=\u20090.43, respectively) in univariate analysis and after further adjustments for potential confounding factors in multivariate analysis. In conclusion, statin use does not impact the prognosis of patients with follicular lymphoma treated with immunochemotherapy. Am. J. Hematol. 91:410\u2013415, 2016. \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ajh.24305","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T00:36:42Z","timestamp":1453509402000},"page":"410-415","source":"Crossref","is-referenced-by-count":8,"title":["<scp>S<\/scp>tatin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: <scp>A<\/scp>n exploratory analysis of the PRIMA cohort study"],"prefix":"10.1002","volume":"91","author":[{"given":"Emmanuel","family":"Bachy","sequence":"first","affiliation":[{"name":"Hematology Department H\u00f4pital Lyon Sud and Universit\u00e9 Claude Bernard Pierre\u2010B\u00e9nite France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Estell","sequence":"additional","affiliation":[{"name":"Hematology Department Concord Hospital Concord NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van de Neste","sequence":"additional","affiliation":[{"name":"Hematology Department Cliniques Universitaires UCL Saint\u2010Luc Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9da","family":"Bouabdallah","sequence":"additional","affiliation":[{"name":"Hematology Department Institut Paoli Calmettes Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bargay","sequence":"additional","affiliation":[{"name":"Hematology Department Hospital Son Ll\u00e0tzer Palma De Mallorca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Delmer","sequence":"additional","affiliation":[{"name":"Hematology Department CHU De Reims Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Gelas\u2010Dore","sequence":"additional","affiliation":[{"name":"Deparment of Biostatistics Lysarc Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gomes da Silva","sequence":"additional","affiliation":[{"name":"Hematology Department Portuguese Institute of Oncology Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fitoussi","sequence":"additional","affiliation":[{"name":"Hematology Department Polyclinique Bordeaux Nord Aquitaine Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Belada","sequence":"additional","affiliation":[{"name":"Hematology Department University Hospital Hradec Kr\u00e0lov\u00e9 Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Maisonneuve","sequence":"additional","affiliation":[{"name":"Hematology Department Centre Hospitalier De La Roche Sur Yon  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanin","family":"Intragumtornchai","sequence":"additional","affiliation":[{"name":"Hematology Department Chulalongkorn University Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lamy","sequence":"additional","affiliation":[{"name":"Hematology Department Centre Hospitalier Pontchaillou Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Dartigues","sequence":"additional","affiliation":[{"name":"Hematology Department Institut Gustave Roussy Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Francis Seymour","sequence":"additional","affiliation":[{"name":"Hematology Department Peter MacCallum Cancer Centre and University of Melbourne Melbourne VIC Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Hematology Department H\u00f4pital Lyon Sud and Universit\u00e9 Claude Bernard Pierre\u2010B\u00e9nite France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.4474"},{"key":"e_1_2_5_3_1","first-page":"75","article-title":"Natural history of and therapy for the indolent non\u2010Hodgkin's lymphomas","volume":"20","author":"Horning SJ.","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.4101"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.10.1470"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.10.3052"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0016"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.3696"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-153189"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.503"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.1561"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.082412"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.7819"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-481341"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201735"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00038-2"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.4757"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050064"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.374751"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4245"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0926-0"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517102"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"e_1_2_5_27_1","first-page":"1055","article-title":"Potential antitumor effects of statins (Review)","volume":"23","author":"Jakobisiak M","year":"2003","journal-title":"Int J Oncol"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.44"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.12444"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L181"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp490"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24305","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24305","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.24305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T09:16:25Z","timestamp":1695546985000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.24305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1002\/ajh.24305"],"URL":"https:\/\/doi.org\/10.1002\/ajh.24305","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]}}}